Page last updated: 2024-11-04

3-hydroxyisobutyric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-hydroxyisobutyric acid: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3-hydroxyisobutyric acid : A 4-carbon, branched hydroxy fatty acid and intermediate in the metabolism of valine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID87
CHEBI ID18064
SCHEMBL ID61073
MeSH IDM0074834

Synonyms (36)

Synonym
CHEBI:18064
2-methyl-3-hydroxypropanoic acid
3-hydroxy-2-methylpropanoic acid
3-hydroxyisobutyric acid
2068-83-9
C01188
FT-0655656
FT-0690514
FT-0669691
k75c8jdf5w ,
unii-k75c8jdf5w
EN300-55072
AKOS008135403
dl-3-hydroxyisobutyric acid
rac 3-hydroxyisobutyric acid
SCHEMBL61073
beta-hydroxyisobutyric acid
DBXBTMSZEOQQDU-UHFFFAOYSA-N
(+/-)-3-hydroxy-2-methylpropanoic acid
.beta.-hydroxyisobutyric acid
propanoic acid, 3-hydroxy-2-methyl-
(s)-3-hydroxy-2-methyl-propionicacid
J-013525
BS-12723
HY-113126
CS-0059643
Q2823215
mfcd11975300
DTXSID20862824
BCP29086
3-hydroxyisobutyric acid pound>>3-hydroxy-2-methylpropanoic acid
A936209
3-hydroxy-2-methyl propanoic acid
rac 3-hydroxyisobutyric acid sodium salt
AB88450
Z431541400

Research Excerpts

Overview

3-Hydroxyisobutyric aciduria is an organic aciduria with a poorly understood biochemical basis. 3HiB is an intermediate in the degradation of the branched-chain amino acid valine.

ExcerptReferenceRelevance
"3-Hydroxyisobutyric acid (3HiB) is an intermediate in the degradation of the branched-chain amino acid valine. "( 3-Hydroxyisobutyrate dehydrogenase (HIBADH) deficiency-A novel disorder of valine metabolism.
Biskup, S; Fobker, M; Hollenbeck, JC; Linden, M; Marquardt, T; Meyer, M; Och, U; Reunert, J; Rust, S; Sass, JO; Seelhöfer, A, 2021
)
2.06
"3-hydroxyisobutyric aciduria is an organic aciduria with a poorly understood biochemical basis. "( 3-Hydroxyisobutyrate aciduria and mutations in the ALDH6A1 gene coding for methylmalonate semialdehyde dehydrogenase.
Atherton, AM; Garg, U; Sass, JO; Scott, D; Shield, JP; Smith, LD; Walter, M; Woods, CG, 2012
)
1.82
"3-Hydroxyisobutyric aciduria is a rare biochemical finding associated with a variable clinical phenotype in the literature. "( 3-Hydroxyisobutyric aciduria: phenotypic heterogeneity within a single family.
Allen, J; Gough, R; Newbury-Ecob, R; Shield, JP, 2001
)
3.2

Effects

ExcerptReferenceRelevance
"3-Hydroxyisobutyric acid has been isolated from the urine of rats loaded with sodium isobutyrate. "( Isolation and identification of S(+)-3-hydroxyisobutyric acid in the urine of rats loaded with isobutyric acid.
Amster, J; Tanaka, K, 1979
)
1.98
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
3-hydroxy monocarboxylic acidA hydroxy monocarboxylic acid that has a hydroxy group beta to the carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Valine degradation817

Research

Studies (36)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (25.00)18.7374
1990's8 (22.22)18.2507
2000's6 (16.67)29.6817
2010's8 (22.22)24.3611
2020's5 (13.89)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.50 (24.57)
Research Supply Index3.66 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.70%)5.53%
Reviews2 (5.41%)6.00%
Case Studies15 (40.54%)4.05%
Observational0 (0.00%)0.25%
Other19 (51.35%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]